#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • A study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis

    Recruiting

    2 1 1
    Investigated Drugs:
    Poland

  • Study of ublituximab compared to fingolimod for children and teenagers aged 10 to 17 years with relapsing multiple sclerosis

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland Slovakia

  • Study comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Greece +4

  • Study on the Safety and Effects of YTB323, Tocilizumab, and Cyclophosphamide in Patients with Relapsing Multiple Sclerosis Who Have Active Disease Despite Treatment

    Recruiting

    1 1 1 1
    Investigated Drugs:
    France Germany Italy Spain

  • Study on the Effectiveness of Ublituximab and Drug Combination for Patients with Relapsing Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous Ocrelizumab in Children and Adolescents with Relapsing‑Remitting Multiple Sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    France Germany Poland

  • Randomized Study of Tolebrutinib Versus Rituximab in Adults with Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark The Netherlands

  • Phase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Bulgaria Denmark France Greece Italy +1